
(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Figure out How to Forestall Tooth Staining - 2
In wrangling dark matter, some scientists find inspiration in the Torah, Krishna and Christ - 3
Israel says 40 Hezbollah members killed as forces advance in Lebanon - 4
Burkina Faso forces killed twice as many civilians as jihadists, rights group says - 5
Drenched in Pixels: A Survey of \Vivid Interactivity Experience\ Game
Comet MAPS faces a make-or-break moment as it dives toward the sun on April 4 — could it shine in the daytime sky?
Scientists find evidence that an asteroid contains tryptophan
January’s full wolf supermoon and the Quadrantid meteor shower will start off the new year
Vote in favor of the pasta that makes good dieting pleasant!
An Ideal Getaway - Spots for Solo Travel
What happened in 'Wicked' part 1 and will there be a 3rd movie? Recap and what Ariana Grande, Jon M. Chu have said about a sequel.
Share your pick for the riding area that characterizes your surf undertakings!
Italy now recognizes the crime of femicide and punishes it with life in prison
Doritos and Cheetos dial back the bright orange in new versions without artificial ingredients













